Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 7, 2014; 20(41): 15358-15366
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15358
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15358
Table 1 Demographics of the study population n
| Characteristics | CD (n =292) | UC (n = 206) | IC (n = 2) |
| Age (yr, mean ± SD) | 41.94 ± 16.3 | 43.2 ± 16.6 | 46.5 ± 37.5 |
| Sex (Male/Female) | 110/182 | 85/121 | 0/2 |
| Race | |||
| African American | 66 (22%) | 37 (18%) | 0 (0%) |
| Asian | 3 (1%) | 2 (1%) | 0 (0%) |
| Native American | 2 (0.7%) | 1 (0.5%) | 0 (0%) |
| White | 200 (68%) | 148 (72%) | 2 (100%) |
| Ethnicity | |||
| Hispanic | 14 (4.8%) | 16 (8%) | 0 (0%) |
| Not hispanic | 278 (95%) | 190 (92%) | 2 (100%) |
| Immunosuppressants | 187 (64%) | 109 (53%) | 2 (100%) |
| IBD disease duration | |||
| (mo, mean ± SD) | 154 ± 138 | 107 ± 106 | 4 ± 4 |
- Citation: Ben Musa R, Gampa A, Basu S, Keshavarzian A, Swanson G, Brown M, Abraham R, Bruninga K, Losurdo J, DeMeo M, Mobarhan S, Shapiro D, Mutlu E. Hepatitis B vaccination in patients with inflammatory bowel disease. World J Gastroenterol 2014; 20(41): 15358-15366
- URL: https://www.wjgnet.com/1007-9327/full/v20/i41/15358.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i41.15358